GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 223 filers reported holding GENMAB A/S in Q4 2020. The put-call ratio across all filers is 1.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,030,769 | -65.2% | 80,264 | -61.0% | 0.00% | – |
| Q4 2022 | $8,711,124 | +487.4% | 205,548 | +350.2% | 0.00% | – |
| Q2 2022 | $1,483,000 | -80.2% | 45,652 | -77.9% | 0.00% | – |
| Q1 2022 | $7,484,000 | +15.8% | 206,862 | +26.6% | 0.00% | – |
| Q4 2021 | $6,462,000 | +980.6% | 163,338 | +1094.1% | 0.00% | – |
| Q3 2021 | $598,000 | -47.9% | 13,679 | -51.3% | 0.00% | – |
| Q2 2021 | $1,147,000 | +81.5% | 28,096 | +45.9% | 0.00% | – |
| Q1 2021 | $632,000 | -75.8% | 19,257 | -70.1% | 0.00% | – |
| Q4 2020 | $2,616,000 | -24.8% | 64,342 | -32.3% | 0.00% | – |
| Q3 2020 | $3,481,000 | +310.0% | 95,081 | +137.2% | 0.00% | – |
| Q1 2020 | $849,000 | – | 40,089 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
| Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
| Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
| XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
| TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
| Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
| Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
| First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
| MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |